search
Back to results

Aerobic Exercise and Brain Health in Multiple Sclerosis

Primary Purpose

Multiple Sclerosis, Brain Atrophy, Cognitive Impairment

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Aerobic exercise
Sponsored by
University of Aarhus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Sclerosis

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Signed consent
  • Definite MS diagnosis
  • Be clarified with the diagnosis and treatment
  • Expectedly able to carry out the aerobic training / test
  • Expanded Disability Status Scale (EDSS) score ≤6.0
  • Must be able to transport themselves to and from training sessions

Exclusion Criteria:

  • Dementia, alcohol abuse or pacemaker
  • Medical comorbidity such as cardiovascular, respiratory, orthopedic or metabolic disorders or other concurrent diseases causing disability and hindering participation in the intervention
  • Disease relapse in a 8 week period prior to study start
  • Pregnancy
  • Metallic implants hindering the MRI scans.
  • Expected training attendance below 85%

Sites / Locations

  • Sport Science, Department of Public Health, Aarhus University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Aerobic exercise

Habitual lifestyle

Arm Description

Aerobic exercise two times per week for 24 weeks.

Habitual lifestyle the first 24 weeks. Will be offered the same exercise intervention after 24 weeks.

Outcomes

Primary Outcome Measures

Percentage brain volume change

Secondary Outcome Measures

Cognition measured by the Brief Repeatable Battery of Neuropsychological Tests
Blood samples: Cytokines and neurotrophins
brain derived neurotrophic factor and key cytokines
VO2max
Regional volume change changes (e.g. hippocampus, thalamus)
Modified Fatigue Impact Scale
Lower score is better. Range 0-84
Fatigue Severity Scale
Lower score is better. Range 9-63.
Major Depression Inventory
Lower score is better. Range 0-50
Short Form 36
Higher score is better. Each item is scored on a 0 to 100 range.
Multiple Sclerosis Impact Scale 29
Converted to a 0-100 scale where 100 indicates greater impact of disease on daily function
6-min walk test
Walk as far as possible in 6 minutes. Higher is better.
Six Spot Step Test
Complete the task as fast as possible. Faster is better.

Full Information

First Posted
January 15, 2016
Last Updated
May 28, 2021
Sponsor
University of Aarhus
Collaborators
Jascha fund, Knud and Edith Eriksens memorial fund, University of Southern Denmark, Augustinus fund, Masku Neurological Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02661555
Brief Title
Aerobic Exercise and Brain Health in Multiple Sclerosis
Official Title
Effects of Aerobic Exercise on Brain Health in People With Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
May 2018
Overall Recruitment Status
Completed
Study Start Date
January 2016 (undefined)
Primary Completion Date
August 2018 (Actual)
Study Completion Date
May 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
Collaborators
Jascha fund, Knud and Edith Eriksens memorial fund, University of Southern Denmark, Augustinus fund, Masku Neurological Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the project is to investigate how aerobic exercise affects brain volume, specific brain regions, neurotrophins and cognition in patients with multiple sclerosis. The study will be a single blinded randomized controlled trial with a 6 months intervention. It is hypothesized that aerobic exercise can slow down brain atrophy, increase the size of hippocampus, upregulate the secretion of neurotrophins and improve cognitive performance in people with multiple sclerosis.
Detailed Description
Multiple Sclerosis (MS) is a physically and cognitively disabling, chronic autoimmune disease of unknown etiology. It is the most common neurological disease affecting young adults in Western countries. According to the Danish MS Registry the prevalence has increased markedly over the last 40 years for particularly women, and today there are approximately 14.000 patients with MS (PwMS) in Denmark. The pathological hallmark of MS is sclerotic plaque. Plaques in the central nervous system (CNS) can be detected in vivo using magnetic resonance imaging (MRI). Both the accumulation of lesions and the accelerated whole-brain atrophy correlate with the progressing physical and cognitive disabilities that clinically characterize PwMS. The disease causes damage of both white and grey matter in the CNS, leading to whole brain atrophy and topographically specific atrophy within the hippocampus and the frontal and temporal cortices. The degradation of the CNS manifests as cognitive and physical disability. Cognitive impairment is estimated to affect up to 65% of PwMS, making it one of the most common and disabling symptoms of MS. Medical therapies for cognitive impairment in MS have so far proved ineffective. Collectively, the prevalence, impact and missing treatments highlight the importance of alternative approaches towards preservation of cognitive function. Despite equivocal findings, aerobic exercise represents a promising approach towards preservation or even expansion of hippocampal volume and cognitive functioning in MS. No longitudinal randomized controlled trial (RCT) study has so far applied the MRI technique when evaluating the potential neuro-protective effect of exercise on brain structure and function in MS. Also, given the scarcity of effective treatments for cognitive impairment in MS, a longitudinal exercise intervention evaluating the potential effect of aerobic exercise on cognition is urgently needed in MS. The purpose of the present project is to investigate how aerobic exercise affects brain volume, specific brain regions, neurotrophins and cognition in PwMS. It is hypothesized that aerobic exercise can slow down brain atrophy, increase the size of hippocampus, upregulate the secretion of neurotrophins and improve cognitive performance in people with MS. The study will be a single blinded RCT. The exercise intervention will contain 6 months of aerobic training (bicycling, rowing and cross trainer) performed two times a week at moderate to high intensity and under supervision. The control group will be "living as usual" and will be offered the same exercise intervention after a 6 month period. A total of approximately 85 PwMS will be expected to be enrolled. The primary outcome of the study will be brain atrophy determined by MRI. The current interdisciplinary project aims to document and understand the possible neuro-protective effects of exercise in MS. This would be of high relevance to PwMS (and other neurological pathologies). From a societal perspective it would help optimize MS rehabilitation and subsequently reduce MS related costs due to disability. In case of positive findings, this would provide the first convincing human evidence of a disease modifying effect of exercise in MS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis, Brain Atrophy, Cognitive Impairment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
86 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aerobic exercise
Arm Type
Experimental
Arm Description
Aerobic exercise two times per week for 24 weeks.
Arm Title
Habitual lifestyle
Arm Type
No Intervention
Arm Description
Habitual lifestyle the first 24 weeks. Will be offered the same exercise intervention after 24 weeks.
Intervention Type
Other
Intervention Name(s)
Aerobic exercise
Primary Outcome Measure Information:
Title
Percentage brain volume change
Time Frame
0, 24 and 48 weeks
Secondary Outcome Measure Information:
Title
Cognition measured by the Brief Repeatable Battery of Neuropsychological Tests
Time Frame
0, 24 and 48 weeks
Title
Blood samples: Cytokines and neurotrophins
Description
brain derived neurotrophic factor and key cytokines
Time Frame
0, 24 and 48 weeks
Title
VO2max
Time Frame
0, 24 and 48 weeks
Title
Regional volume change changes (e.g. hippocampus, thalamus)
Time Frame
0, 24 and 48 weeks
Title
Modified Fatigue Impact Scale
Description
Lower score is better. Range 0-84
Time Frame
0, 24 and 48 weeks
Title
Fatigue Severity Scale
Description
Lower score is better. Range 9-63.
Time Frame
0, 24 and 48 weeks
Title
Major Depression Inventory
Description
Lower score is better. Range 0-50
Time Frame
0, 24 and 48 weeks
Title
Short Form 36
Description
Higher score is better. Each item is scored on a 0 to 100 range.
Time Frame
0, 24 and 48 weeks
Title
Multiple Sclerosis Impact Scale 29
Description
Converted to a 0-100 scale where 100 indicates greater impact of disease on daily function
Time Frame
0, 24 and 48 weeks
Title
6-min walk test
Description
Walk as far as possible in 6 minutes. Higher is better.
Time Frame
0, 24 and 48 weeks
Title
Six Spot Step Test
Description
Complete the task as fast as possible. Faster is better.
Time Frame
0, 24 and 48 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Signed consent Definite MS diagnosis Be clarified with the diagnosis and treatment Expectedly able to carry out the aerobic training / test Expanded Disability Status Scale (EDSS) score ≤6.0 Must be able to transport themselves to and from training sessions Exclusion Criteria: Dementia, alcohol abuse or pacemaker Medical comorbidity such as cardiovascular, respiratory, orthopedic or metabolic disorders or other concurrent diseases causing disability and hindering participation in the intervention Disease relapse in a 8 week period prior to study start Pregnancy Metallic implants hindering the MRI scans. Expected training attendance below 85%
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin L Christensen, MSc
Organizational Affiliation
University of Aarhus
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sport Science, Department of Public Health, Aarhus University
City
Aarhus
State/Province
Aarhus C
ZIP/Postal Code
8000
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33262230
Citation
Langeskov-Christensen M, Grondahl Hvid L, Nygaard MKE, Ringgaard S, Jensen HB, Nielsen HH, Petersen T, Stenager E, Eskildsen SF, Dalgas U. Efficacy of High-Intensity Aerobic Exercise on Brain MRI Measures in Multiple Sclerosis. Neurology. 2021 Jan 12;96(2):e203-e213. doi: 10.1212/WNL.0000000000011241. Epub 2020 Dec 1.
Results Reference
derived
PubMed Identifier
33232191
Citation
Langeskov-Christensen M, Hvid LG, Jensen HB, Nielsen HH, Petersen T, Stenager E, Hamalainen P, Dalgas U. Efficacy of high-intensity aerobic exercise on cognitive performance in people with multiple sclerosis: A randomized controlled trial. Mult Scler. 2021 Sep;27(10):1585-1596. doi: 10.1177/1352458520973619. Epub 2020 Nov 24.
Results Reference
derived

Learn more about this trial

Aerobic Exercise and Brain Health in Multiple Sclerosis

We'll reach out to this number within 24 hrs